Creo Medical Group (CREO) Competitors GBX 9.60 -0.15 (-1.54%) As of 12:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock CREO vs. EKF, IUG, NCYT, POLX, IHC, AVO, RUA, MHC, SUN, and BELLShould you be buying Creo Medical Group stock or one of its competitors? The main competitors of Creo Medical Group include EKF Diagnostics (EKF), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), MyHealthChecked (MHC), Surgical Innovations Group (SUN), and Belluscura (BELL). These companies are all part of the "medical devices" industry. Creo Medical Group vs. EKF Diagnostics Intelligent Ultrasound Group Novacyt Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences MyHealthChecked Surgical Innovations Group Belluscura EKF Diagnostics (LON:EKF) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, community ranking, profitability and institutional ownership. Does the MarketBeat Community believe in EKF or CREO? EKF Diagnostics received 221 more outperform votes than Creo Medical Group when rated by MarketBeat users. Likewise, 76.76% of users gave EKF Diagnostics an outperform vote while only 67.52% of users gave Creo Medical Group an outperform vote. CompanyUnderperformOutperformEKF DiagnosticsOutperform Votes32776.76% Underperform Votes9923.24% Creo Medical GroupOutperform Votes10667.52% Underperform Votes5132.48% Does the media prefer EKF or CREO? In the previous week, EKF Diagnostics' average media sentiment score of 0.00 equaled Creo Medical Group'saverage media sentiment score. Company Overall Sentiment EKF Diagnostics Neutral Creo Medical Group Neutral Do insiders & institutionals believe in EKF or CREO? 70.3% of EKF Diagnostics shares are held by institutional investors. Comparatively, 56.1% of Creo Medical Group shares are held by institutional investors. 5.2% of EKF Diagnostics shares are held by insiders. Comparatively, 22.4% of Creo Medical Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, EKF or CREO? EKF Diagnostics has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, Creo Medical Group has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Is EKF or CREO more profitable? EKF Diagnostics has a net margin of 9.37% compared to Creo Medical Group's net margin of -73.93%. EKF Diagnostics' return on equity of 7.03% beat Creo Medical Group's return on equity.Company Net Margins Return on Equity Return on Assets EKF Diagnostics9.37% 7.03% 5.27% Creo Medical Group -73.93%-41.79%-20.09% Which has preferable earnings and valuation, EKF or CREO? EKF Diagnostics has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEKF Diagnostics£49.91M1.87£4.68M£1.0719.54Creo Medical Group£33.87M1.15-£25.04M-£6.32-1.52 SummaryEKF Diagnostics beats Creo Medical Group on 11 of the 13 factors compared between the two stocks. Get Creo Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CREO vs. The Competition Export to ExcelMetricCreo Medical GroupMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£38.81M£3.13B£5.44B£2.53BDividend YieldN/A2.45%5.43%4.96%P/E Ratio-1.5266.2922.14131.54Price / Sales1.15117.49389.70238,740.39Price / Cash2.4315.9938.2028.05Price / Book0.733.656.664.49Net Income-£25.04M£126.02M£3.21B£5.82B7 Day Performance-1.03%0.21%5.83%8.73%1 Month Performance-25.15%-9.19%-4.32%7.28%1 Year Performance-73.34%-14.04%17.83%25.27% Creo Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CREOCreo Medical GroupN/AGBX 9.60-1.5%N/A-72.2%£38.81M£33.87M-1.52279EKFEKF DiagnosticsN/AGBX 21.20-1.9%N/A-26.0%£94.23M£49.91M19.73356IUGIntelligent Ultrasound GroupN/AN/AN/AN/A£42.76M£6.57M-18.9165NCYTNovacytN/AGBX 41.70+0.8%N/A-43.8%£28.81M£18.12M-0.77120POLXPolarean ImagingN/AGBX 1.07+4.4%N/A-72.3%£15.70M£5.21M-0.2828IHCInspiration Healthcare GroupN/AGBX 16.95+1.2%N/A-46.4%£14.68M£42.87M-1.16224AVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.95+6.2%N/A+14.7%£7.42M£4.05M-2.7948Gap UpMHCMyHealthCheckedN/AGBX 13-7.1%N/A+40.0%£6.77M£9.43M-6.4816Gap DownSUNSurgical Innovations GroupN/AGBX 0.55+10.0%N/A+22.1%£5.13M£12.54M-21.1180Gap DownBELLBelluscuraN/AGBX 0.71-5.6%N/A-91.3%£1.79M£2.87M-0.0824Gap Down Related Companies and Tools Related Companies EKF Diagnostics Competitors Intelligent Ultrasound Group Competitors Novacyt Competitors Polarean Imaging Competitors Inspiration Healthcare Group Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors MyHealthChecked Competitors Surgical Innovations Group Competitors Belluscura Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CREO) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CREO Stock Free CREO Stock Alerts